共 50 条
- [41] Treatment of patients with inoperable stage III or stage IV melanoma. Societe francaise de dermatologie ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 413 - 422
- [42] Factors associated with the use of adjuvant radiation therapy in stage III melanoma FRONTIERS IN ONCOLOGY, 2023, 13
- [43] Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 11 - 12
- [45] Re-evaluation of treatment understanding and quality of life of patients with stage III/IV melanoma after completion of adjuvant therapy or one year of follow-up JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 55 - 55
- [46] Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma CANCER MEDICINE, 2023, 12 (03): : 2378 - 2388
- [48] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162
- [50] Clinical experience with adjuvant treatment of patients with Stage III melanoma of the trunk and extremities in a developing country REVISTA COLOMBIANA DE CANCEROLOGIA, 2015, 19 (01): : 10 - 17